Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: characterization and in vitro evaluation as sustained release systems

References

• Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 2008; 5: 505–15
   PubMed Web of Science ®Google Scholar
• Au JL, Jang SH, Zheng J, Chen CT, Song S, Hu L, Wientjes MG. Determinants of drug delivery and transport to solid tumors. J Control Release 2001; 74: 31–46
   PubMed Web of Science ®Google Scholar
• Blanco MD, Guerrero S, Benito M, Teijon C, Olmo R, Muñiz E, Katime I, Teijon JM. Tamoxifen-loaded folate-conjugate poly[(p-nitrophenylacrylate)-co-(Nisopropylacrylamide)] sub-microgel as antitumoral drug delivery system. J Biomed Mater Res A 2010; 95A: 1028–40
   Web of Science ®Google Scholar
• Blanco MD, Sastre RL, Teijon C, Olmo R, Teijon JM. Degradation behaviour of microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers. Int J Pharm 2006; 326: 139–47
   PubMed Web of Science ®Google Scholar
• Byrne J, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliver Rev 2008; 60: 1615–26
   PubMed Web of Science ®Google Scholar
• Cha Y, Pitt CG. The acceleration of degradation controlled drug delivery from polyester microspheres. J Control Release 1989; 8: 259–65
   Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002; 249: 127–38
   PubMed Web of Science ®Google Scholar
• Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008; 14: 1310–16
   PubMed Web of Science ®Google Scholar
• Coezy E, Borgna JL, Rochefort H. Tamoxifen and metabolites in MCF7 cells: Correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 1982; 42: 317–23
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 2010; 148: 135–46
   PubMed Web of Science ®Google Scholar
• Davda J, Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 2002; 233: 51–9
   PubMed Web of Science ®Google Scholar
• Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 1997; 14: 1568–73
   PubMed Web of Science ®Google Scholar
• Duh JL, Yu R, Jiao JJ, Matwyshyn GA, Li W, Tan TH, Kong AN. Activation of signal transduction kinases by tamoxifen. Pharm Res 1997; 14: 186–9
   PubMed Web of Science ®Google Scholar
• Faraji AH, Wipf P. Nanoparticles in cellular drug delivery. Bioorg Med Chem 2009; 17: 2950–62
   PubMed Web of Science ®Google Scholar
• Freitas MN, Marchetti JM. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases. Int J Pharm 2005; 295: 201–11
   PubMed Web of Science ®Google Scholar
• Garcia-Fuentes M, Prego C, Torres D, Alonso MJ. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery. Eur J Pharm Sci 2005; 25: 133–43
   PubMed Web of Science ®Google Scholar
• Ge H, Hu S, Yang S, Jiang X, Yang C. Preparation, characterization and drug release behaviors of drug loaded ε-caprolactone/L-lactide copolymer nanoparticles. J Appl Polym Sci 2000; 75: 874–82
   Web of Science ®Google Scholar
• Grenman S, Shapira A, Carey TE. In vitro response of cervical cancer cell lines CaSki, HeLa, and ME-180 to the antiestrogen tamoxifen. Gynecol Oncol 1988; 30: 228–38
   PubMed Web of Science ®Google Scholar
• Gundimeda U, Chen ZH, Gopalakrishna R. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. J Biol Chem 1996; 271: 13504–14
   PubMed Web of Science ®Google Scholar
• Han X, Liu J, Liu M, Xie C, Zhan C, Gu B, Liu Y, Feng L, Lu W. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: Preparation and evaluation in vitro. Int J Pharm 2009; 372: 125–31
   PubMed Web of Science ®Google Scholar
• Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Cur Opinion Solid State Mater Sci 2002; 6: 319–27
   Web of Science ®Google Scholar
• Hombreiro M, Zinutti C, Lamprecht A, Ubrich N, Astier A, Hoffman M, Bodmeier R, Maincent P. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J Control Release 2000; 65: 429–38
   PubMed Web of Science ®Google Scholar
• Jain RK. Delivery of molecular medicine to solid tumors. Science 1996; 271: 1079–80
   PubMed Web of Science ®Google Scholar
• Jain RK. Delivery of molecular and cellular medicine to solid tumors. J Control Release 1998; 53: 49–67
   PubMed Web of Science ®Google Scholar
• Jalil RNJ. Microencapsulation using poly(L-lactic acid): II. Preparative variables affecting microcapsule properties. J Microencapsulation 1990a; 7: 25–39
   PubMed Web of Science ®Google Scholar
• Jalil RNJ. Microencapsulation using poly(L-lactic acid) III: Effect of the polymer molecular weight on the microcapsule properties. J Microencapsulation 1990b; 7: 41–52
   PubMed Web of Science ®Google Scholar
• Jalil RNJ. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsule containing phenobarbitone. J Microencapsulation 1990c; 7: 53–66
   PubMed Web of Science ®Google Scholar
• Jeffery H, Davis SS, O'Hagan DT. The preparation and characterization of poly(lactide-co-glycolide) microparticles: II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res 1993; 10: 362–8
   PubMed Web of Science ®Google Scholar
• Jordan VC. Tamoxifen: Toxicities and drug resistance during the treatment and prevention of breast cancer. Annu Rev Pharmacol Toxicol 1995; 35: 195–211
   PubMed Web of Science ®Google Scholar
• Kim BS, Kim CS, Lee KM. The intracellular uptake ability of chitosan-coated poly(D,L-lactide-co-glycolide) nanoparticles. Arch Pharm Res 2008; 31: 1050–4
   PubMed Web of Science ®Google Scholar
• Kumari A, Kumar S, Yadav S. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surfaces B: Biointerfaces 2010; 75: 1–18
   PubMed Web of Science ®Google Scholar
• Lammers T, Kiessling F, Hennink W, Storm G. Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress. J Control Release 2011, in press
   Web of Science ®Google Scholar
• Lassalle V, Ferreira ML. PLA nano- and microparticles for drug delivery: An overview of the methods of preparation. Macromol Biosci 2007; 7: 767–83
   PubMed Web of Science ®Google Scholar
• Lee JW, Gardell JA, Hicks W, Hard R, Frank V. Bright analysis of the initial burst of drug release coupled with polymer surface degradation. Pharm Res 2003a; 20: 149–52
   PubMed Web of Science ®Google Scholar
• Lee SC, Oh JT, Jang MH, Chung SI. Quantitative analysis of polyvinyl alcohol on the surface of poly(D,L-lactide-co-glycolide) microparticles prepared by solvent evaporation method: Effect of particle size and PVA concentration. J Control Release 1999; 59: 123–32
   PubMed Web of Science ®Google Scholar
• Lee KH, Ward BA, Desta Z, Flockhart DA, Jones DR. Quantification of tamoxifen and three metabolites in plasma by high-performance liquid chromatography with fluorescence detection: Application to a clinical trial. J Chromatogr B Analyt Technol Biomed Life Sci 2003b; 791: 245–53
   PubMed Web of Science ®Google Scholar
• Lemoine D, Francois C, Kedzierewicz F, Preat V, Hoffman M, Maincent P. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Biomaterials 1996; 17: 2191–7
   PubMed Web of Science ®Google Scholar
• Letchford K, Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: Micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 2007; 65: 259–69
   PubMed Web of Science ®Google Scholar
• López-Gasco P, Iglesias I, Benedí J, Lozano R, Teijón JM, Blanco MD. Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: In vitro bioactivity evaluation. J Microencapsulation 2011; 28: 417–29
   PubMed Web of Science ®Google Scholar
• MacCallum J, Cummings J, Dixon JM, Miller WR. Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in plasma. J Chromatogr B Biomed Appl 1996; 678: 317–23
   PubMed Web of Science ®Google Scholar
• Maulding HV, Tice TR, Cowsar DR, Fong JW, Pearson JE, Nazareno JP. Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. J Control Release 1986; 3: 103–17
   Google Scholar
• McClean S, Prosser E, Meehan E, O'Malley D, Clarke N, Ramtoola Z, Brayden D. Binding and uptake of biodegradable poly-D,L-lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci 1998; 6: 153–63
   PubMed Web of Science ®Google Scholar
• Nagahara L, Lee J, Molnar L, Panaro N, Farrell D, Ptak K, Alper J, Grodzinski P. Strategic workshops on cancer nanotechnology. Cancer Res 2010; 70: 4265–8
   PubMed Web of Science ®Google Scholar
• Nkansah MK, Tzeng SY, Holdt AM, Lavik EB. Poly(lactic-co-glycolic acid) nanospheres and microspheres for short- and long-term delivery of bioactive ciliary neurotrophic factor. Biotechnol Bioeng 2008; 100: 1010–19
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Singh M. Microparticles as vaccine adjuvants and delivery systems. Wiley, WeinheimGermany 2004
   Google Scholar
• Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55: 329–47
   PubMed Web of Science ®Google Scholar
• Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. Int J Pharm 2003; 262: 1–11
   PubMed Web of Science ®Google Scholar
• Pinto C, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation: I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2006; 2: 8–21
   PubMed Web of Science ®Google Scholar
• Prasad J, Geckeler K. Polymer nanoparticles: Preparation technique and size-control parameters. Prog Polym Sci 2011; 36: 887–913
   Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly(D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 2002; 82: 105–14
   PubMed Web of Science ®Google Scholar
• Sastre RL, Blanco MD, Teijon C, Olmo R, Teijon JM. Preparation and characterization of 5-fluorouracil-loaded poly (ε-caprolactone) microspheres for drug administration. Drug Develop Res 2004; 63: 41–53
   Web of Science ®Google Scholar
• Sastre RL, Olmo R, Teijon C, Muniz E, Teijon JM, Blanco MD. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers. Int J Pharm 2007; 338: 180–90
   PubMed Web of Science ®Google Scholar
• Shang Y, Brown M. Molecular determinants for the tissue specificity of SERMs. Science 2002; 295: 2465–8
   PubMed Web of Science ®Google Scholar
• Siepmann J, Gopferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev 2001; 48: 229–47
   PubMed Web of Science ®Google Scholar
• Singh R, Lillard JW, Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009; 86: 215–23
   PubMed Web of Science ®Google Scholar
• Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-epsilon-caprolactone microspheres and nanospheres: An overview. Int J Pharm 2004; 278: 1–23
   PubMed Web of Science ®Google Scholar
• Sivalingham G, Madras G. Thermal degradation of binary physical mixtures and copolymers of poly(ε-caprolactone), poly(D,L-lactide), and poly(glycolide). Pol Degradat and Stab 2004; 84: 393–8
   Web of Science ®Google Scholar
• Tanaka T, Decuzzi P, Cristofanilli M, Sakamoto JH, Tasciotti E, Robertson FM, Ferrari M. Nanotechnology for breast cancer therapy. Biomed Microdevices 2009; 11: 49–63
   PubMed Web of Science ®Google Scholar
• Thombre AG, Cardinal JR. Biopolymers for controlled drug delivery. Marcel Dekker, New York 1990
   Google Scholar
• Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 2008; 364: 298–327
   PubMed Web of Science ®Google Scholar
• Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001; 22: 231–41
   PubMed Web of Science ®Google Scholar
• Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ, Labrude P, Vigneron C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release 1998; 50: 31–40
   PubMed Web of Science ®Google Scholar